Product Description:
Vanderbilt Kennedy Research Ethics Grand Rounds: It is now possible to receive a non-invasive prenatal test for Down syndrome that can be administered at 10 weeks of gestation and reportedly has 99% accuracy. As technology advances and allows for genetic tests such as MaterniT21 to be developed, what ethical considerations arise?
Panelists:
Robert Hodapp, Ph.D., Moderator, Professor of Special Education and Director of Research, Vanderbilt Kennedy Center UCEDD
Frank Boehm, M.D., Professor of Obstetrics and Gynecology and Associate Professor of Radiology and Radiological Sciences;
Martha Dudek, M.S., L.C.G.C., Genetic Counselor Senior Associate in Obstetrics and Gynecology Associate in Pediatrics;
Christine Sartain, Parent advocate